Investigating checkpoint inhibitor-induced gastrointestinal disease: comparisons with idiopathic ulcerative colitis and health
In the last decade, immunotherapy with anti-PD1 and anti-CTLA4 drugs has revolutionized the treatment of metastatic cancer. A significant proportion of patients given these checkpoint inhibitors develop off-target inflammation in the colon (checkpoint inhibitor-induced colitis, CC). Ulcerative colit...
| मुख्य लेखक: | |
|---|---|
| अन्य लेखक: | |
| स्वरूप: | थीसिस |
| भाषा: | English |
| प्रकाशित: |
2022
|
| विषय: |